Author:
Li Ruoyan,Strobl Johanna,Poyner Elizabeth F.M.,Torabi Fereshteh,Mazin Pasha,Chipampe Nana-Jane,Stephenson Emily,Gardner Louis,Olabi Bayanne,Coulthard Rowen,Botting Rachel A.,Zila Nina,Prigmore Elena,Gopee Nusayhah,Engelbert Justin,Goh Issac,Chan Hon Man,Johnson Harriet,Ellis Jasmine,Rowe Victoria,Tun Win,Reynolds Gary,Foster April Rose,Gambardella Laure,Winheim Elena,Admane Chloe,Rumney Benjamin,Steele Lloyd,Jardine Laura,Nenonen Julia,Pickard Keir,Lumley Jennifer,Hampton Philip,Hu Simeng,Liu Fengjie,Liu Xiangjun,Horsfall David,Basurto-Lozada Daniela,Grimble Louise,Bacon Chris M.,Weatherhead Sophie,Brauner Hanna,Wang Yang,Bai Fan,Reynolds Nick J.,Allen Judith E.,Jonak Constanze,Brunner Patrick M.,Teichmann Sarah A.,Haniffa Muzlifah
Abstract
AbstractCutaneous T-cell lymphoma (CTCL) is a potentially fatal clonal malignancy of T cells primarily affecting the skin. The most common form of CTCL, mycosis fungoides (MF), can be difficult to diagnose resulting in treatment delay. The pathogenesis of CTCL is not fully understood due to limited data from patient studies. We performed single-cell RNA sequencing and spatial transcriptomics profiling of skin from patients with MF-type CTCL, and an integrated comparative analysis with human skin cell atlas datasets from healthy skin, atopic dermatitis and psoriasis. We reveal the co-optation of Th2-immune gene programmes by malignant CTCL cells and modelling of the tumour microenvironment to support their survival. We identify MHC-II+fibroblast subsets reminiscent of lymph node T-zone reticular cells and monocyte-derived dendritic cells that can maintain Th2-like tumour cells. CTCL Th2-like tumour cells are spatially associated with B cells, forming aggregates reminiscent of tertiary lymphoid structures which are more prominent with progressive disease. Finally, we validated the enrichment of B cells in CTCL skin infiltrates and its association with disease progression across three independent patient cohorts. Our findings provide diagnostic aids, potential biomarkers for disease staging and therapeutic strategies for CTCL.
Publisher
Cold Spring Harbor Laboratory